Tag: Motley Fool

  • When the music stops… the investment bankers stop getting paid!

    You’ve heard the one about The Beatles’ album which, when played backwards, says ‘Paul is dead’, right?

    It was a fun conspiracy theory (though it was a simpler time — imagine what they’d find on it these days with 5G chips in every COVID vaccination!).

    It was, of course, untrue.

    I haven’t had my COVID vaccine yet (they’re booked out!), but I expect my phone signal to improve when I do.

    (I can’t decide whether to make sure you know I’m kidding, or just watch the emails roll in from those who think I’m serious. Somehow, I don’t think I’m going to stop them, either way, but for the record, I’ll be getting the jab as soon as I can. And no, it’s not some Bill Gates New World Order plot.)

    Now, where was I?

    That’s right — songs being played backwards.

    There’s something of an ASX analogy — it’s not a conspiracy, but it’s equally silly — which plays out, in one form or another, almost continuously.

    It’s the forwards-backwards dance of acquisition-and-spinoff, merger-and-demerger.

    The latest, of course, is Westpac’s reported consideration of parting ways with its New Zealand operations.

    That news comes on the heels of Treasury Wine Estates (I own shares) considering spinning off the Penfolds brand.

    And Crown, back in the day, trying to list its property assets in a separate entity.

    Woolies is about to spin off Endeavour Drinks.

    It’s kind of a trend.

    But it’s not a one-way story.

    Google (I own shares) once-upon-a-time bought YouTube.

    IOOF has acquired MLC.

    Ramsay Health is buying UK hospitals.

    Carsales bought 49% of a US classifieds mob.

    And there’s Tabcorp, which is either being taken over, selling assets, or spinning them off. It kinda depends what day it is!

    Then there’s the merry-go-round:

    It wasn’t that long ago that Treasury itself was merged into Carlton & United Breweries. Then spun out.

    Or that long ago that our banks bought into NZ, and strapped on wealth management arms (now also all-but gone).

    Woolies bought — and then sold — EziBuy, the online catalogue retailer.

    BHP has had as chequered a career as anyone on that front, too.

    You’d almost be forgiven — and forgive me, as I drop into an almost-conspiratorial whisper — for thinking that the common thread here is ‘activity’, maybe even encouraged by investment banks and brokers who (I know, I’m surprised too), stand to make a cut of the transaction.

    Surely not.

    Right?

    Well, I’ll let you make your own decision on that one.

    What I will say is that CEOs and company boards, like the rest of us, find it bloody hard to resist the temptation to just leave things alone.

    They feel compelled to tinker, driven by the idea that they might be able to ‘create value’ through the ‘synergies’ of a merger, or the ‘increased focus’ of a divestiture.

    That both can’t be simultaneously true seems to elude them, or perhaps they just think they’re the exception to the rule.

    After all, CEOs don’t get the big chair by lacking confidence…

    And the blame doesn’t lie just with CEOs, either.

    We investors are happy to accept — or sometimes even encourage — the sort of thinking that gives us what I’ve decided to call ‘piano accordion capitalism’(™).

    In. Out. In. Out. In. Out.

    When we bid up a company’s share price after they announce a merger, we’re implicitly approving the decision.

    When one company becomes two — and the market capitalisation of the two businesses is higher than when they were a single company — we’re justifying the decision.

    Why wouldn’t a CEO do those things, when they’re given share price ‘applause’ as a result?

    We’re also very fickle, though — if things don’t work out, we’re only too happy to knife the incumbent and blame him for our problems.

    It’s good to be the king.

    So which is it?

    Should we be cheering on mergers?

    Or pushing for divestments?

    Or should we be wary of acquisitions and preferring our companies to keep their businesses intact?

    Alas, dear reader, there is no easy answer.

    There are plenty of cases that support the ‘don’t just sit there, do something’ approach, and plenty of cases that make you wish the top brass had just played golf that day, instead.

    Which is, in its way, the point.

    If something is a crapshoot, doesn’t it stand to reason that, for all of the costs, hassle, disruption and uncertainty, the better course of action is just to leave well enough alone?

    It’s a pipedream, of course.

    CEOs spend their lives with investment bankers and short-term investors in their ears; exhorting them, in Warren Buffett’s baseball metaphor, to ‘swing, ya bum’!

    And so, the decision falls to us, as investors.

    If we can’t control the CEOs and boards, we can at least control our own emotions and decisions.

    And we can remember that the motivation of those who would make these things happen is almost always short-term in nature. So, the bottom line is, unfortunately, that we should be sceptical.

    As a Treasury shareholder, I hope the company resists the urge to demerge its crown jewel, even if, in the short term, the combined price jumps a little.

    If I was a bank shareholder, I’d want Westpac to keep its NZ operations — and I’m on record as saying I think the banks will rue spinning off their wealth management businesses. After all, long term mortgage debt can only rise as fast as wages (plus or minus any change in interest rates), while wealth management has a long term, compounding, tailwind!

    Again, though, some spin offs will be good for shareholders. And some acquisitions will truly create long term value.

    So there’s no easy answer other than, as Buffett’s right hand man Charlie Munger would suggest, to keep an eye on the incentives at play — and to keep a slightly sceptical countenance.

    (Alternatively, if you want to buy all of the parts of my car for more than the market is offering for the whole thing, give me a call. I’m sure we can come to an arrangement!)

    Fool on!

    The post When the music stops… the investment bankers stop getting paid! appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3w5SMhC

  • 3 reasons why the VanEck Vectors Morningstar Wide Moat ETF (ASX:MOAT) could be a quality investment

    The VanEck Vectors Morningstar Wide Moat ETF (ASX: MOAT) could be a really interesting exchange-traded fund (ETF) investment to think about.

    There are a number of different reasons why this ETF could offer some good characteristics to investors.

    Here are three reasons to consider it:

    Quality

    Morningstar analysts are the people responsible for deciding which businesses make it into the portfolio, hence why it’s part of the ETF’s name. Only businesses with a strong economic moat can make it into the portfolio.

    Morningstar analysts assign an economic moat rating to each of the approximately 1,500 companies under its coverage.

    An economic moat is a sustainable competitive advantage that allows a company to generate positive economic profits for owners over an extended period.

    For a company to be assessed to have a wide economic moat, excess normalised returns must, with near certainty, be positive 10 years from now. In addition, excess normalised returns must, more likely than not, be positive 20 years from now.

    The duration of forecast profit is far more important for Morningstar than the absolute magnitude.

    Diversification

    Whilst all of the businesses in this portfolio are listed in the US, they offer satisfactory levels of diversification.

    It has a high allocation to growing sectors and a small weighting to slow-growth industries. At the end of April 2021, the weightings were: healthcare (20.4%), information technology (17%), industrials (15.2%), financials (12.9%), consumer staples (11%), communication services (7.2%), consumer discretionary (6.2%), materials (5%), energy (2.7%) and utilities (2.4%).

    VanEck Vectors Morningstar Wide Moat ETF doesn’t own hundreds of shares, but it has around 50 positions. This may provide a satisfactory level of diversification.

    There isn’t a lot of position concentration. The largest position in the portfolio is a 3.2% allocation to Wells Fargo. Other positions in the top 10 include: Cheniere Energy, Alphabet, Northrop Grumman, Philip Morris, Raytheon Technologies, General Dynamics, Berkshire Hathaway, Blackbaud and Altria.

    Other positions further down the portfolio include Yum! Brands, Constellation brands, Lockheed Martin, Boeing, Kellogg, Pfizer, Intel, Amazon and Salesforce.com.

    Outperformance in net return terms

    Past performance is not an indicator of future returns, however the historical net returns of VanEck Vectors Morningstar Wide Moat ETF have been better than the S&P 500 over the shorter-term and the longer-term.

    Over the six months to 30 April 2021, the ETF’s total return was 25% compared to the S&P 500’s return of 16.9%. Over the last five years the ETF has delivered an average return per annum of 18.6%, compared to the S&P 500’s average return per annum of 16.5%.

    The post 3 reasons why the VanEck Vectors Morningstar Wide Moat ETF (ASX:MOAT) could be a quality investment appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/2RqLQgc

  • DGL Group (ASX:DGL) share price falls despite positive announcement

    The DGL Group Ltd (ASX: DGL) share price headed south today despite the company announcing its growth initiatives are underway.

    At the end of market trade, the chemical company’s shares were swapping hands for $1.26, down 2.69%.

    What did DGL announce?

    DGL couldn’t catch a break today, with investors offloading the company’s shares despite its positive release.

    According to the statement, the DGL board has approved plans to develop its new chemicals storage warehouse.

    DGL will seek to expand commercial operations at its existing Mount Wellington warehousing and distribution facility in Auckland, New Zealand. The cost to develop the warehouse is expected to be around NZ$4.5 million (A$4.2 million).

    Construction works have been awarded to Robert Cunningham Construction, which has more than 25 years’ experience in the industry. Furthermore, the project will be managed by New Zealand’s leading independent project management company, MPM Projects.

    Construction of the warehouse will begin in July, with completion scheduled for the end of the year.

    Management commentary

    DGL founder and CEO Simon Henry said of the expansion plans:

    Mount Wellington is a large, sought-after and key distribution hub for the Auckland metro region. The new state-of-the-art facility will provide increased storage for current clients and enable new clients to gain access to the precinct. We expect the warehouse to be fully occupied soon after opening.

    The new warehouse is the first of a number of site expansions planned across the Trans-Tasman in the next 12 months, to ensure that we are able to provide the capacity the industry requires and to further cement our position as the leading service provider to the chemical industry in Australia and New Zealand.

    More on the warehouse

    DGL acquired the 1.8-hectare site in 2012, and the company has spent 9 years bringing its specialised chemical storage facility online.

    The Mount Wellington site is currently licenced to store up to 6,000 tonnes of chemicals. The new warehouse will provide the company with an additional 2,000 tonnes of capacity. It will take DGL’s total capacity to 128,000 tonnes across all its facilities from Perth, Western Australia to Christchurch.

    DGL share price snapshot

    Operating across Australia, New Zealand and internationally, DGL offers chemical formulation and manufacturing services, warehousing and distribution, waste management, and environmental solutions.

    Since listing on the ASX early last week at a price of $1.00 per share, the DGL share price has gained 26%. Based on the current share price, the company has a market capitalisation of roughly $325 million.

    The post DGL Group (ASX:DGL) share price falls despite positive announcement appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3uWp5i0

  • Why the Antisense (ASX:ANP) share price rocketed 16% today

    The Antisense Therapeutics Limited (ASX: ANP) share price soared today without any news out of the company. It seems the market may have been a bit slow on the uptake and was responding to news released by the junior healthcare company earlier in the week. On Tuesday, Antisense released an announcement regarding a muscular dystrophy study.

    The company provided an update on its meeting with the United States Food and Drug Administration (FDA) in relation to the inhibitor ATL1102. At close of trading today, the biotechnology company’s shares were up 15.79% to 22 cents. This followed gains on Thursday’s session as well.

    What’s drove the Antisense share price higher?

    The rise in Antisense shares followed the release earlier this week of the FDA’s official minutes on the company’s Type C guidance meeting.

    According to the statement, the FDA has given the nod for Antisense to explore higher dosage limits of ATL1102 in future studies. This follows the recent data findings of Antisense’s Phase II open-label study in Melbourne. A total of 9 Duchenne muscular dystrophy (DMD) patients received 25 milligrams of ATL1102 per week for 24 weeks.

    Furthermore, Antisense said the FDA has accepted the company’s proposed design of its Phase IIb/III study. The clinical trial will run for 52 weeks during which time participants will be assessed for muscle strength. The FDA also suggested Antisense submits a study protocol, outlining primary and secondary endpoints.

    A 9-month monkey toxicology study will also be conducted into the effects of ATL1102. However, the FDA said once the animal study is at the report-writing stage, the Phase IIb/III human trial can begin.

    Antisense is now consulting with US-based regulatory advisors regarding the next steps towards starting the Phase IIb/III human trial. In addition, the company is evaluating the cost and feasibility of the 9-month monkey study.

    About Antisense and ATL1102

    Founded in 2000, Antisense is focused on developing and commercialising antisense pharmaceuticals for patients suffering from rare diseases. Antisense is the non-coding DNA strand of a gene.

    The company is developing ATL1102, an antisense inhibitor of the CD49d receptor, for DMD patients. Recently Antisense reported promising Phase II trial results, indicating a significantly reduced number of brain lesions in patients with relapsing-remitting multiple sclerosis.

    DMD is a severe type of muscular dystrophy that primarily affects boys. According to Antisense, it occurs as a result of mutations in the dystrophin gene which cause a substantial reduction in, or absence of, the dystrophin protein.

    Ongoing deterioration in muscle strength affects lower limbs, leading to impaired mobility, and can also affect upper limbs, leading to further loss of function and self-care ability.

    Over the past 12 months, the Antisense share price has jumped by almost 230%. Antisense shares are also up by around 70% year to date.

    The post Why the Antisense (ASX:ANP) share price rocketed 16% today appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ifOO20

  • 3 highly rated ASX growth shares analysts love

    There are a lot of growth shares for investors to choose from on the Australian share market.

    To narrow things down, I have picked out three ASX growth shares that are highly rated. Here’s what you need to know about them:

    ELMO Software Ltd (ASX: ELO)

    ELMO is a HR and payroll platform provider. It has been growing at an impressive rate over the last few years thanks to solid demand for its offering in the ANZ and UK markets and acquisitions. Positively, the company looks well-placed to continue this positive form thanks to the shift to the cloud, its significant addressable market, and cross- and up-selling opportunities.

    One broker that is particularly positive on ELMO is Shaw & Partners. It currently has a buy rating and and $9.00 price target.

    IDP Education Ltd (ASX: IEL)

    IDP Education is a provider of international student placement services and English language testing services. As you might expect, it was hit hard by the pandemic. However, thanks to its software business and strong balance sheet, the company has been tipped to win market share and resume its rapid growth once the crisis passes.

    Morgan Stanley is positive on the company’s post-pandemic prospects. As a result, it recently retained its overweight rating and $30.00 price target on the IDP Education’s shares.

    ResMed Inc. (ASX: RMD)

    Another growth share to look at is ResMed. It is a medical device company with a focus on the sleep treatment market. Thanks to its industry-leading products, wide distribution, and successful acquisitions, ResMed has been growing at a very strong rate over the last few years. Pleasingly, thanks to its significant market opportunity and the growing prevalence of sleep disorders, it has been tipped to continue doing so for the foreseeable future.

    Credit Suisse is a fan of the company and believes upcoming launch of its new CPAP device, AirSense 11, will be a key driver of growth. The broker has an outperform rating and $29.00 price target on its shares.

    The post 3 highly rated ASX growth shares analysts love appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3g8LvHd

  • These 3 shares were the biggest gainers of the ASX 200 this week

    It’s been a good week for the S&P/ASX 200 Index (ASX: XJO), which has gained 1.68% since last Friday’s close. Though, these 3 shares have blown the ASX 200’s gains out of the water.

    Let’s take a look at this week’s best performing shares of the index.

    This week’s top performers

    Origin Energy Ltd (ASX: ORG) – up 15.7%

    Origin shares enjoyed a stellar week on the ASX despite there being no news out of the company.

    But, as Motley Fool reported yesterday, the ASX 200 energy producer’s share price has been boosted by surging commodity prices, which underpinned solid gross domestic product (GDP) growth.

    By the end of the week, the Origin Energy share price was trading at $4.72.

    Worley Ltd (ASX: WOR) – up 15.6%

    Since last Friday’s close, the Worley share price has gained an impressive 15.6% as a result of multiple announcements.

    On Tuesday, the ASX 200 engineering company announced 2 contract wins – one with Celanese and another with Shell.

    Worley’s contract with Celanese will see it conducting the engineering, procurement and construction of Celanese’s new acetic acid unit in Texas, United States.

    Its contract for Shell will involve building a green hydrogen hub in the Netherlands.

    Despite the good news, the Worley share price dropped during Tuesday’s trade – closing 0.5% lower than its previous session.

    Luckily for shareholders, however, on Wednesday Worley released its investor day presentation. The presentation indicated that the company is set to deliver improved performance for the second half of the 2021 financial year.

    Finally, Worley received multiple positive broker notes on Thursday as a result of its investor day presentation.

    At Friday’s close, Worley shares were fetching $12.25 apiece.

    Inghams Group Ltd (ASX: ING) – up 12.2%

    This week, the Inghams share price seems to have been still basking in the glory of the company’s 2021 financial year earnings and guidance update, released last Friday.

    The guidance seemed to exceed the market’s expectations, since the company’s shares gained 10% that day.

    Then, on Monday, a note out of Goldman Sachs sent the poultry producer’s share price soaring once more when analysts retained their buy rating and lifted their price target on the Inghams share price to $4.50.

    On Wednesday, Credit Suisse followed Goldman Sachs’ example. Credit Suisse retained its outperform rating on Inghams shares and lifted its price target to $4.10

    Currently, one share in Inghams will set an investor back $3.83.

    The post These 3 shares were the biggest gainers of the ASX 200 this week appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3uKnpYE

  • Should you buy ANZ (ASX:ANZ) and Sydney Airport (ASX:SYD) for their dividends?

    Earlier this week the Reserve Bank of Australia elected to keep rates on hold again. Unfortunately for income investors, this looks likely to remain the case for some time to come.

    The good news is that there are a large number of dividend shares with attractive yields ready to save the day. Two such examples are listed below:

    Australia and New Zealand Banking GrpLtd (ASX: ANZ)

    If you don’t already have exposure to the banking sector, then it could be worth considering ANZ. Especially given its improving outlook and the prospect of dividend increases in the coming years.

    One broker that is particularly positive on ANZ is Morgans. The broker recently retained its add rating and lifted its price target on the bank’s shares to $33.50. This compares to the latest ANZ share price of $29.20.

    In addition to this, the broker is forecasting fully franked dividends of $1.45 and $1.63 per share over the next two financial years. Based on the current ANZ share price, this will mean yields of 5% and 5.6%, respectively.

    Sydney Airport Holdings Pty Ltd (ASX: SYD)

    Another ASX dividend share to look at is Sydney Airport. While trading conditions are tough for the airport operator right now, it looks well-placed to rebound once travel markets return to normal.

    Goldman Sachs expects this to be the case. The broker recently retained its buy rating and $6.73 price target on its shares.

    And while Goldman isn’t expecting much by way of dividends in FY 2021, it appears confident that things will normalise next year. The broker is forecasting dividends of 8.8 cents per share in FY 2021 and then 27.1 cents per share in FY 2022.

    Based on the current Sydney Airport share price of $6.12, this will mean yields of 1.4% and 4.6%, respectively.

    The post Should you buy ANZ (ASX:ANZ) and Sydney Airport (ASX:SYD) for their dividends? appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3fPo4Uz

  • 3 exciting ASX tech shares to watch

    If you’re interested in making long term investments in tech shares, then you might want to check out the shares listed below.

    All three have high quality products with long runways for growth. Here’s why they are worth watching closely:

    Nitro Software Ltd (ASX: NTO)

    The first ASX tech share to look at is Nitro Software. Its Nitro Productivity Suite is driving digital transformation in businesses around the world across multiple industries. Demand for the solution, which provides integrated PDF productivity and electronic signature tools, has been growing strongly over the last few years. This underpinned a 64% increase in annualised recurring revenue (ARR) to $27.7 million in FY 2020. Positively, similarly strong growth is expected in FY 2021. Management is guiding to ARR in the range of $39 million to $42 million. This will mean year on year growth of 41% to 51.6%.

    Pushpay Holdings Group Ltd (ASX: PPH)

    Another tech share to look at is Pushpay. It is a leading donor management and community engagement platform provider for the faith sector. As with Nitro, demand for its offering has been growing strongly. This is being driven by the accelerating digitisation of the church and the shift to a cashless society. This strong demand led to Pushpay recently reporting a 40% increase in operating revenue to US$179.1 million and a 133% increase in EBITDAF to US$58.9 million for FY 2021. Looking ahead, management is forecasting further growth in FY 2022 and is planning to expand into a new market.

    Whispir Ltd (ASX: WSP)

    A final tech share to look at is Whispir. It is a software-as-a-service communications workflow platform provider. Whispir provides an industry-leading software platform that allows governments and organisations to deliver actionable two-way interactions at scale using automated multi-channel communication workflows. It counts a growing number of blue chips as customers. These include AGL Energy Limited (ASX: AGL), BP, ING, and KPMG to name just a few. Whispir is currently generating ARR of $50.3 million, which is just a fraction of its total addressable market of US$4.7 billion in just the United States.

    The post 3 exciting ASX tech shares to watch appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3g2AkQo

  • ASX 200 rises, Appen drops, Reject Shop discounted

    The S&P/ASX 200 Index (ASX: XJO) rose by another 0.5% today to 7,295 points.

    Here are some of the highlights from the ASX:

    Appen Ltd (ASX: APX)

    The Appen share price fell 6.3% today after news came of the sale of shares by a member of the leadership team.

    The CEO and managing director of Appen, Mark Brayan, has sold 109,430 shares. This sale was to satisfy tax obligations arising from the vesting of 173,153 performance rights in March 2021.

    Appen pointed out that Mr Brayan continues to hold 482,032 shares of the ASX 200 company directly and indirectly and has 294,033 performance rights available subject to meeting vesting conditions.

    Reject Shop Ltd (ASX: TRS)

    The Reject Shop share price fell around 6% after giving a trading update to the market.

    Since the release of the half-year result, trading activity has continued to be challenging. The company’s stores in CBD locations and large shopping centres, typically in metro areas, continue to trade well below pre COVID-19 levels.

    Preliminary and unaudited comparable sales for the first 48 weeks ended 30 May 2021 were down 1.4% compared to the comparable period in FY19. To contextualise this result, comparable sales at CBD locations and large shopping centres, amounting to 47 stores, were down 12%. The rest of the portfolio, comprising 290 stores, saw comparable sales up 0.9%.

    In addition to the above, Reject Shop continues to incur materially increased supply chain costs, particularly higher international shipping costs as well as costs associated with holding inventory due to international shipping delays.

    Management have been working to offset these headwinds through cost reduction. Reject Shop is expecting full-year sales for FY21 to be in the range of $776 million to $778 million. Pre AASB-16 earnings before interest and tax (EBIT) is expected to be in the range of $8 million to $10 million.

    Reject Shop said that it continues to look for new locations, particularly in regional Australia, where it can more conveniently serve more Australians. The national store footprint has increased to 359 stores, up from 354 stores at the half-year result announcement. The company expects to progressively open a further two stores in June and nine stores in the first quarter of FY22.

    Reject Shop concluded by saying that it’s focused on cost reductions. However, it has achieved substantial progress during the ‘fix’ phase of the turnaround strategy. The company said its balance sheet remains strong and is expected to support the growth strategy.

    Primewest Group Ltd (ASX: PWG) and Centuria Capital Group (ASX: CNI)

    It was announced today that the Primewest founding directors John Bond, David Schwartz and Jim Litis, who with their associates together own around 53% of Primewest, have accepted the takeover bid from Centuria Capital Group.

    As a result of this, shareholders that own around 76% of Primewest shares have provided acceptances to Centuria.

    Centuria has declared that the offer is now unconditional.

    Primewest investors who have accepted the offer will receive $0.20 in cash as well as 0.473 Centuria securities for each Primewest security they own, within five business days.

    The post ASX 200 rises, Appen drops, Reject Shop discounted appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/3ceqZ76

  • 2 fantastic ASX shares that could be quality buy and hold options

    If you’re looking to invest in a growth share or two, then you might want to consider the ones listed below.

    Here’s why these ASX shares could be top options for growth investors looking at long term buy and hold options:

    Afterpay Ltd (ASX: APT)

    This buy now pay later (BNPL) provider could be a quality buy and hold option. This is due to its extremely positive long term growth outlook.

    Afterpay has been growing at a rapid rate in recent years and looks well placed to continue this trend in the years to come. This is thanks to its leadership position in the growing BNPL industry and its expansion into other financial products and geographies.

    In respect to the former, a recent note out of Macquarie reveals that it believes the BNPL market could be worth as much as A$3.8 trillion by 2030. Given its leadership position, this can only be good news for Afterpay.

    It is partly for this reason that Macquarie upgraded the company’s shares to an outperform rating with a $120.00 price target late last month.

    NEXTDC Ltd (ASX: NXT)

    Another ASX share to consider as a buy and hold investment is NEXTDC. Its 11 world class Tier III and Tier IV data centre facilities across Australia appear well-placed to benefit greatly from increasing demand thanks to the cloud computing boom.

    This boom is being driven by more and more services becoming cloud-based and businesses continuing to shift in-house infrastructure into data centres.

    And while the structural shift to the cloud has accelerated during the pandemic, it still has a long way to go. This is expected to underpin strong sales and profit growth for the foreseeable future. In fact, a significant amount of NEXTDC’s future capacity has already being contracted, which gives investors good visibility on its future earnings.

    Looking ahead, the company is planning to expand into the Asia market. It recently opened up offices in Singapore and Tokyo with a view of entering these markets in the near future. If this expansion is a success, then it would give NEXTDC an even longer runway for growth over the 2020s.

    Goldman Sachs is bullish on NEXTDC. Its analysts currently have a buy rating and $15.00 price target on its shares.

    The post 2 fantastic ASX shares that could be quality buy and hold options appeared first on The Motley Fool Australia.

    from The Motley Fool Australia https://ift.tt/34O1ftT